Upregulation of the long noncoding RNA GJA9‐MYCBP and PVT1 is a potential diagnostic biomarker for acute lymphoblastic leukemia
Cancer Reports · 2024
DOI: 10.1002/cnr2.2115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Kamal Shahamiri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Biomarkers, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Up-Regulation. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahrekord University of Medical Sciences.
Abstract (Originalsprache)
Background
Acute lymphoblastic leukemia (ALL) is the most common type of blood cancer in children. Aberrant expression of long noncoding RNAs (lncRNAs) may set stages for ALL development. LncRNAs are emerging as a novel diagnostic and prognostic biomarker for ALL. Herein, we aimed to evaluate the expression of lncRNA GJA9‐MYCBP and PVT1 in blood samples of ALL and healthy individuals.
Methods
As a case–control study, 40 pairs of ALL and healthy individual samples were used. The expression of MYC and each candidate lncRNA was measured using quantitative real‐time PCR. Any possible association between the expression of putative noncoding RNAs and clinicopathological characteristics was also evaluated.
Results
LncRNA GJA9‐MYCBP and PVT1 were significantly upregulated in ALL samples compared with healthy ones. Similarly, mRNA levels of MYC were increased in ALL samples than control ones. Receiver operating characteristic curve analysis indicated a satisfactory diagnostic efficacy ( p ‐value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
- Thalassemia & Hemoglobinopathy Research center, Health research institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Hematology and Blood Transfusion, School of Allied Medical Sciences, Tehran University of Medical science, Tehran, Iran.
ORCID-Profile: Kamal Shahamiri, Arash Alghasi, Hossein Teimori, Gholam Abbas Kaydani, Setare Sheikhi
Förderung
- Shahrekord University of Medical Sciences
Zitieren
APA
Shahamiri, K., Alghasi, A., Saki, N., Teimori, H., Kaydani, G. A., & Sheikhi, S. (2024). Upregulation of the long noncoding RNA GJA9‐MYCBP and PVT1 is a potential diagnostic biomarker for acute lymphoblastic leukemia. Cancer Reports. https://doi.org/10.1002/cnr2.2115
Vancouver
Shahamiri K, Alghasi A, Saki N, Teimori H, Kaydani GA, Sheikhi S. Upregulation of the long noncoding RNA GJA9‐MYCBP and PVT1 is a potential diagnostic biomarker for acute lymphoblastic leukemia. Cancer Reports. 2024. doi:10.1002/cnr2.2115
BibTeX
@article{Shahamiri2024,
author = {Shahamiri, Kamal and Alghasi, Arash and Saki, Najmaldin and Teimori, Hossein and Kaydani, Gholam Abbas and Sheikhi, Setare},
title = {Upregulation of the long noncoding RNA GJA9‐MYCBP and PVT1 is a potential diagnostic biomarker for acute lymphoblastic leukemia},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.2115}
}
EUVIMED